Nobukazu Kakui
Pharmaceutical Research Center
Meiji Seika Kaisha
Ltd. 760
Morooka-cho
Japan
Name/email consistency: high
- Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor. Kakui, N., Yokoyama, F., Yamauchi, M., Kitamura, K., Imanishi, T., Inoue, T., Koyama, T. Pharmacol. Biochem. Behav. (2009)
- Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway. Kakui, N., Kitamura, K. Endocrinology (2007)
- Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor. Kakui, N., Tanaka, J., Tabata, Y., Asai, K., Masuda, N., Miyara, T., Nakatani, Y., Ohsawa, F., Nishikawa, N., Sugai, M., Suzuki, M., Aoki, K., Kitaguchi, H. J. Pharmacol. Exp. Ther. (2006)